Journal
BIOMATERIALS SCIENCE
Volume 6, Issue 11, Pages 2951-2964Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c8bm00910d
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81470783, 81400550, 31370957]
- Natural Science Foundation of Guangdong Province [2015A030311051, 2016A030310173]
- Shenzhen Innovative Technology Commission Grant [JCYJ20160429190821781, JCYJ20160429185449249]
- Hong Kong Research Grant Council General Research Funds (RGC GRF) [718913E, 17214516, 772113M, N HKU725-16]
- Hong Kong Innovation Technology Fund [ITS/287/17]
- Hong Kong Health and Medical Research Fund [03142446]
Ask authors/readers for more resources
Xenograft, namely bone-derived biological apatite (BAp), is widely recognized as a favorable biomaterial in bone tissue engineering owing to its biodegradability, biocompatibility, and osteoconductive properties. Substitutions of endogenous trace ions are thought to improve the osteogenic capacity of xenograft compared with synthetic hydroxyapatite (HAp). In order to modify the physicochemical and biological properties of apatite, different approaches to induce trace ion incorporation have been widely considered. In this study, we demonstrated that the incorporation of fluoride ions into porcine bone-derived biological apatite (pBAp) contributes to altered crystal morphology of the apatite, the sustained release of fluoride, and the in situ release of endogenous trace ions (e.g., magnesium and calcium) into the peripheral tissue microenvironment. This ionic balanced perimaterial microenvironment not only led to superior proliferation and osteogenic differentiation of rat bone mesenchymal stem cells (rBMSCs), but also accelerated new bone formation of the calvarial defect on a rat model via the activation of Wnt/-catenin signaling. These promising observations may be attributed to the controlled release of endogenous trace ions from the xenograft to the peripheral tissue microenvironment driven by fluoride ion incorporation. Lastly, this study may provide a new insight to strengthen the osteogenicity of xenografts for clinical applications in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available